GCIA
SRDX

Gabelli & Co Investment Advisers’s Surmodics SRDX Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-159,835
Closed -$4.78M – 320
2025
Q3 		$4.78M Sell
159,835
-43,752
-21% -$1.46M 0.77% 33
2025
Q2 		$6.05M Buy
203,587
+8,200
+4% +$236K 0.93% 30
2025
Q1 		$5.97M Buy
195,387
+66,150
+51% +$2.23M 0.9% 34
2024
Q4 		$5.12M Buy
129,237
+7,800
+6% +$303K 0.87% 34
2024
Q3 		$4.71M Buy
121,437
+49,337
+68% +$2M 0.8% 38
2024
Q2 		$3.03M Buy
+72,100
New +$2.46M 0.51% 49

Other funds holding SRDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Gabelli & Co Investment Advisers's SRDX Position: Q4 2025 in Review

Gabelli & Co Investment Advisers sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 159,835 shares — an estimated $4.78M sold.

Gabelli & Co Investment Advisers first reported a position in SRDX in Q2 2024 and held it in 6 quarters. The position peaked at $6.05M in Q2 2025. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • Gabelli & Co Investment Advisers reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 159,835 Surmodics shares in Q4 2025, an estimated $4.78M.
  • Gabelli & Co Investment Advisers first reported a position in Surmodics in Q2 2024 and held it in 6 quarters.
  • Gabelli & Co Investment Advisers's Surmodics position peaked at $6.05M in Q2 2025.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2025, filed 5 Feb 2026.